tiprankstipranks
Trending News
More News >
CleanGo Innovations (TSE:CGII)
:CGII

CleanGo Innovations (CGII) AI Stock Analysis

Compare
0 Followers

Top Page

TSE:CGII

CleanGo Innovations

(CGII)

Select Model
Select Model
Select Model
Neutral 46 (OpenAI - 5.2)
Rating:46Neutral
Price Target:
C$0.39
▼(-12.89% Downside)
Action:UpgradedDate:12/30/25
The score is held down primarily by weak financial performance (shrinking revenue, very large losses, negative equity, and continued cash burn). Technicals also remain bearish with the stock below key moving averages and negative MACD, despite near-oversold readings. Corporate events provide some upside optionality, but are not yet enough to offset the financial and trend risks.
Positive Factors
Improved gross margin
Gross margin rising to roughly 29% TTM indicates meaningful improvement in unit economics and pricing or cost structure. If sustained, stronger gross margins provide a durable foundation to absorb SG&A and R&D, making a path to profitability more achievable as revenue stabilizes and scales.
Reduced cash burn vs 2024
Operating and free cash flow have become materially less negative versus 2024, showing the company is narrowing its cash burn. This structural improvement extends runway, reduces near-term financing pressure, and improves the firm’s ability to execute strategic initiatives without immediate dilution if the trend continues.
Corporate events create diversification optionality
Recent corporate actions—new product, joint venture into remediation, acquisition LOI and a CAD 300k private placement—represent structural diversification and incremental funding. These moves expand addressable markets and provide execution levers that can alter growth trajectory if implemented successfully.
Negative Factors
Shrinking revenue
Revenue contraction of roughly 14.5% TTM reduces scale and undermines operating leverage. With lower top-line volume, fixed costs become a heavier burden, limiting the realisation of improved gross margins and making it harder to reach sustainable profitability without stabilizing or reversing revenue trends.
Very large sustained losses
Extremely negative net margins (~-890% TTM) show operating costs still vastly exceed gross profit. Persistent, large losses erode capital and force reliance on external financing or severe cost cuts, constraining strategic investment and making long-term recovery dependent on significant structural changes.
Negative shareholder equity, weak balance sheet
Consistently negative equity (~-0.8M TTM) and declining assets signal accumulated deficits and limited financial flexibility. Even with modest absolute debt, negative equity weakens creditor confidence, raises refinancing risk, and constrains the company’s ability to fund operations or pursue growth without dilutive or costly capital.

CleanGo Innovations (CGII) vs. iShares MSCI Canada ETF (EWC)

CleanGo Innovations Business Overview & Revenue Model

Company DescriptionCleanGo Innovations Inc. manufactures and sells non-toxic, biodegradable cleaning, disinfecting, and industrial solutions. It offers industrial, fabrics and carpets, and total purpose cleaners; hand sanitizers; and sanitary wipes under the CleanGo GreenGo brand. CleanGo Innovations Inc. is headquartered in Calgary, Canada.
How the Company Makes MoneyCleanGo Innovations generates revenue primarily through the sale of its eco-friendly cleaning products. These products are distributed through various retail and online channels, allowing the company to reach a broad customer base. Key revenue streams include direct sales to consumers, partnerships with retailers, and bulk orders from corporate clients seeking sustainable cleaning solutions. The company may also engage in strategic partnerships with other eco-conscious brands or distributors to expand its market presence and enhance its product offerings.

CleanGo Innovations Financial Statement Overview

Summary
Financials remain very weak: revenue is down ~14.5% TTM and losses widened sharply with extremely negative net margins, while shareholder equity is consistently negative. Positives include a large gross margin improvement (~29% TTM) and reduced cash burn versus 2024, but operating cash flow and free cash flow are still negative.
Income Statement
12
Very Negative
The business remains structurally unprofitable. TTM (Trailing-Twelve-Months) revenue declined about 14.5% versus the prior annual period, while losses widened materially (net margin fell to roughly -890% in TTM vs. about -464% in 2024). A key positive is that gross margin has improved dramatically versus earlier years (deeply negative in 2022 to ~29% in TTM), suggesting better unit economics; however, operating costs still overwhelm gross profit, driving very large operating and net losses.
Balance Sheet
18
Very Negative
Balance-sheet quality is weak, primarily due to consistently negative shareholder equity across all periods (including ~-0.8M in TTM), which signals accumulated deficits and reduces financial flexibility. Total debt is moderate in absolute terms (about 0.35M in TTM, down from ~0.63M in 2023–2024), but with negative equity the capital structure remains strained and leverage indicators are not economically reassuring. Total assets have also trended down from 2023 levels, limiting the cushion available to absorb ongoing losses.
Cash Flow
20
Very Negative
Cash generation remains negative, with TTM (Trailing-Twelve-Months) operating cash flow around -0.10M and free cash flow around -0.13M, indicating continued cash burn. The positive development is a meaningful improvement in cash burn versus 2024 (free cash flow less negative), and cash outflows are far smaller than in 2020–2021; however, the company is still not funding itself internally, and ongoing losses are not being offset by positive operating cash flow.
BreakdownTTMMar 2025Mar 2024Mar 2023Mar 2022Mar 2021
Income Statement
Total Revenue178.73K209.04K222.05K113.89K146.76K190.35K
Gross Profit51.31K88.11K91.90K-115.19K18.34K6.18K
EBITDA-1.35M-643.35K-480.76K-1.59M-6.90M-587.08K
Net Income-1.59M-970.02K-738.66K-1.68M-6.95M-622.85K
Balance Sheet
Total Assets321.94K366.46K842.35K592.43K1.12M600.38K
Cash, Cash Equivalents and Short-Term Investments156.94K101.33K296.73K14.11K295.75K212.05K
Total Debt349.35K627.08K633.26K372.61K51.03K920.49K
Total Liabilities1.19M1.56M1.26M1.50M1.48M1.72M
Stockholders Equity-808.22K-1.20M-412.95K-1.20M-364.10K-1.12M
Cash Flow
Free Cash Flow-125.97K-357.39K-256.76K-216.05K-1.21M-1.18M
Operating Cash Flow-101.87K-357.39K-256.76K-216.05K-1.20M-1.09M
Investing Cash Flow-24.10K0.000.000.00923.92K-86.75K
Financing Cash Flow242.19K179.71K537.71K-64.82K357.62K1.38M

CleanGo Innovations Technical Analysis

Technical Analysis Sentiment
Negative
Last Price0.45
Price Trends
50DMA
0.48
Negative
100DMA
0.55
Negative
200DMA
0.60
Negative
Market Momentum
MACD
0.02
Positive
RSI
41.03
Neutral
STOCH
33.33
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:CGII, the sentiment is Negative. The current price of 0.45 is below the 20-day moving average (MA) of 0.53, below the 50-day MA of 0.48, and below the 200-day MA of 0.60, indicating a bearish trend. The MACD of 0.02 indicates Positive momentum. The RSI at 41.03 is Neutral, neither overbought nor oversold. The STOCH value of 33.33 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for TSE:CGII.

CleanGo Innovations Peers Comparison

Overall Rating
UnderperformOutperform
Sector (62)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
73
Outperform
C$1.42B22.5512.97%2.67%11.25%58.21%
62
Neutral
$20.33B14.63-3.31%3.23%1.93%-12.26%
62
Neutral
C$109.74M5.60%7.04%-39.19%
46
Neutral
C$3.44M-1.41-25.05%-19.86%
39
Underperform
C$23.86M-6.90-179.43%-391.89%
* Consumer Defensive Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
TSE:CGII
CleanGo Innovations
0.47
0.17
56.67%
TSE:GLG.H
GLG Life Tech
0.04
0.00
0.00%
TSE:KPT
KP Tissue
10.95
3.50
46.94%
TSE:JWEL
Jamieson Wellness Inc
34.39
6.46
23.14%
TSE:VICE
Vice Health and Wellness
0.01
0.00
0.00%
TSE:URAI
Pure to Pure Beauty Inc.
0.20
0.07
53.85%

CleanGo Innovations Corporate Events

Business Operations and StrategyProduct-Related Announcements
CleanGo Innovations Taps Cyprus Hub to Launch CleanGo Marine Division
Positive
Feb 3, 2026

CleanGo Innovations Inc., a global provider of proprietary, non-toxic green technology solutions for multiple industries, is expanding its reach into the maritime sector with eco-certified cleaning and protection products aimed at helping clients meet tightening environmental and ESG standards. The company has signed an exclusive agency agreement with WSR Services LTD in Cyprus to spearhead the global launch and Mediterranean expansion of its new CleanGo Marine division, centered on CG-M100, a Green Seal certified, MARPOL-compliant dispersant for vessel and tanker cleaning. Leveraging Cyprus as a strategic hub for ship management and targeting ship repair and conversion markets, the partnership is expected to open high-level access to European and Middle Eastern shipping corridors, while CleanGo also explores a low-cost manufacturing and distribution base in Athens. The move positions CleanGo more firmly in the marine and shipping protection space and underscores rising demand for non-toxic, regulatory-compliant solutions among regional stakeholders and global ship owners.

The most recent analyst rating on (TSE:CGII) stock is a Sell with a C$0.38 price target. To see the full list of analyst forecasts on CleanGo Innovations stock, see the TSE:CGII Stock Forecast page.

Business Operations and StrategyProduct-Related Announcements
CleanGo Innovations Enters South America with First CG-100 Shipment to Argentina
Positive
Jan 29, 2026

CleanGo Innovations Inc. has secured approval from its long-established Argentinian partner Indioquímica S.A. for the first shipment of 6,000 liters of its CG-100 industrial cleaner, marking the company’s official entry into the South American market. The deployment of CG-100, a non-toxic, biodegradable alternative to hazardous caustic chemicals in oil and gas production, anchors CleanGo’s push into one of the region’s key industrial hubs and positions the firm to tap rising demand for high-performance, ESG-compliant solutions in heavy industry and energy, with plans to expand into ports, shipping fleets and broader industrial applications over time.

The most recent analyst rating on (TSE:CGII) stock is a Hold with a C$0.44 price target. To see the full list of analyst forecasts on CleanGo Innovations stock, see the TSE:CGII Stock Forecast page.

Business Operations and StrategyProduct-Related Announcements
CleanGo Innovations Launches MycoSet Globally, Targets Saudi and GCC Oilfield Remediation Market
Positive
Jan 8, 2026

CleanGo Innovations has launched its MycoSet oilfield remediation technology globally, positioning its Saudi Arabian subsidiary, CleanGo Arabia, at the center of expansion into Saudi Arabia and the wider Gulf Cooperation Council markets. The MycoSet suite, which includes the BioIngress biostimulant and PhytoCentra surfactant, is engineered to work in extreme arid and hypersaline environments and offers in‑situ hydrocarbon cleanup that the company says can outperform traditional mechanical and thermal methods while cutting logistics costs by up to 60% and water use by 85%. By emphasizing biological restoration of contaminated soils and aligning with regional partners such as Sanad Industrial Co., CleanGo aims to tap into tightening environmental regulations, support Saudi Vision 2030 objectives and establish a cost‑effective, nature‑based remediation standard for some of the world’s largest energy operators, potentially strengthening its competitive position in the global oilfield services and green technologies markets.

The most recent analyst rating on (TSE:CGII) stock is a Hold with a C$0.49 price target. To see the full list of analyst forecasts on CleanGo Innovations stock, see the TSE:CGII Stock Forecast page.

Business Operations and StrategyM&A Transactions
CleanGo Innovations Expands into Global Health with Acquisition of Freia Farmaceutici
Positive
Dec 17, 2025

CleanGo Innovations Inc., through its subsidiary Kubera Black Technology, has entered a non-binding Letter of Intent to acquire Milan-based Freia Farmaceutici Srl, a European leader in plant-based therapeutics. This strategic move allows CleanGo to expand its reach into the global health sector, leveraging Freia’s expertise in vegetable omega-based medical devices, nutritional supplements, and innovative therapeutic solutions. The acquisition will grant Freia access to North American markets while providing CleanGo with diversified industry positioning and potential revenue growth opportunities.

Private Placements and Financing
CleanGo Innovations Secures CAD 300,000 Through Private Placement
Positive
Dec 9, 2025

CleanGo Innovations Inc. has announced a private placement to raise CAD 300,000 by issuing 500,000 units at CAD 0.60 each. This funding initiative involves both existing and new investors and is subject to regulatory and stock exchange approvals. The move is expected to bolster CleanGo’s financial position and support its mission to innovate in the green cleaning industry, potentially enhancing its market presence and stakeholder value.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Dec 30, 2025